We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · November 14, 2019

ACAAI 2019: Benefits of Mepolizumab in Real World for Asthma Approach Those Seen in Trials

Reduction in asthma exacerbations leading to hospitalization was not significant, however

PracticeUpdate Editorial Team

 

Further Reading